- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 21-03-2026: Press Release
21-03-2026 | 08:16 am
21-03-2026 | 08:16 am
Zydus launched Semaglutide Injection with an innovative, reusable multi-dose pen in India for diabetes/obesity. This key business development lowers monthly therapy cost to ~Rs. 2,200, tapping into a significant and growing market for Zydus.
No comments yet. Be the first to comment!